IL159670A0 - Use of il-18 binding protein in inflammations - Google Patents
Use of il-18 binding protein in inflammationsInfo
- Publication number
- IL159670A0 IL159670A0 IL15967003A IL15967003A IL159670A0 IL 159670 A0 IL159670 A0 IL 159670A0 IL 15967003 A IL15967003 A IL 15967003A IL 15967003 A IL15967003 A IL 15967003A IL 159670 A0 IL159670 A0 IL 159670A0
- Authority
- IL
- Israel
- Prior art keywords
- inflammations
- binding protein
- protein
- binding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15967003A IL159670A0 (en) | 2003-12-31 | 2003-12-31 | Use of il-18 binding protein in inflammations |
EP04806701A EP1699823A2 (en) | 2003-12-31 | 2004-12-27 | Use of il-18 binding protein in inflammations |
US10/584,805 US20070264237A1 (en) | 2003-12-31 | 2004-12-27 | Use of Il-18 Binding Protein in Inflammations |
AU2004308763A AU2004308763B2 (en) | 2003-12-31 | 2004-12-27 | Use of IL-18 binding protein in inflammations |
CA002552155A CA2552155A1 (en) | 2003-12-31 | 2004-12-27 | Use of il-18 binding protein in inflammations |
JP2006546476A JP5420151B2 (ja) | 2003-12-31 | 2004-12-27 | 炎症におけるil−18結合性タンパク質の使用 |
PCT/IL2004/001170 WO2005063290A2 (en) | 2003-12-31 | 2004-12-27 | Use of il-18 binding protein in inflammations |
IL176324A IL176324A (en) | 2003-12-31 | 2006-06-15 | Protein IL-18 binder for the preparation of anti-inflammatory drugs |
NO20063458A NO20063458L (no) | 2003-12-31 | 2006-07-27 | Anvendelse av IL-18-bindende protein ved betennelser |
US13/027,449 US20110177065A1 (en) | 2003-12-31 | 2011-02-15 | Methods of treating/preventing inflammation using combination of il-1 antagonist and il-18 binding protein |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IL15967003A IL159670A0 (en) | 2003-12-31 | 2003-12-31 | Use of il-18 binding protein in inflammations |
Publications (1)
Publication Number | Publication Date |
---|---|
IL159670A0 true IL159670A0 (en) | 2004-06-01 |
Family
ID=33485385
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15967003A IL159670A0 (en) | 2003-12-31 | 2003-12-31 | Use of il-18 binding protein in inflammations |
IL176324A IL176324A (en) | 2003-12-31 | 2006-06-15 | Protein IL-18 binder for the preparation of anti-inflammatory drugs |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL176324A IL176324A (en) | 2003-12-31 | 2006-06-15 | Protein IL-18 binder for the preparation of anti-inflammatory drugs |
Country Status (8)
Country | Link |
---|---|
US (2) | US20070264237A1 (ja) |
EP (1) | EP1699823A2 (ja) |
JP (1) | JP5420151B2 (ja) |
AU (1) | AU2004308763B2 (ja) |
CA (1) | CA2552155A1 (ja) |
IL (2) | IL159670A0 (ja) |
NO (1) | NO20063458L (ja) |
WO (1) | WO2005063290A2 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7968684B2 (en) | 2003-11-12 | 2011-06-28 | Abbott Laboratories | IL-18 binding proteins |
US7767206B2 (en) | 2006-10-02 | 2010-08-03 | Amgen Inc. | Neutralizing determinants of IL-17 Receptor A and antibodies that bind thereto |
WO2008131315A2 (en) | 2007-04-20 | 2008-10-30 | Amgen Inc. | Jacquelinidentification and method for using the pre-ligand assembly domain of the il-17 receptor |
TW201117824A (en) | 2009-10-12 | 2011-06-01 | Amgen Inc | Use of IL-17 receptor a antigen binding proteins |
PT3295957T (pt) | 2010-01-15 | 2019-11-12 | Kirin Amgen Inc | Formulação de anticorpo anti il-17ra e regimes terapêuticos para o tratamento de psoríase |
DE102011118024A1 (de) * | 2011-08-01 | 2013-02-07 | Technische Universität Dresden | Inhibitor der Expression der Pro-Caspase 1 |
GB201400997D0 (en) * | 2014-01-21 | 2014-03-05 | Vib Vzw | Targeting of interleukin-1 and -18 in treatment of septic shock |
KR102511343B1 (ko) | 2015-03-05 | 2023-03-17 | 에이비2 바이오 에스에이 | 염증성 질환에서 il-18 결합 단백질(il-18bp) 및 항체 |
KR20220044057A (ko) * | 2020-09-29 | 2022-04-06 | 주식회사 에이프릴바이오 | 인터루킨-18 결합 단백질 및 혈청 알부민에 대한 항원 결합 단편을 포함하는 융합 단백질, 및 이의 용도 |
WO2024029331A1 (ja) * | 2022-07-30 | 2024-02-08 | 国立大学法人 東京医科歯科大学 | 関節疾患の治療及び/又は予防に用いるための医薬組成物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2288429C (en) * | 1991-03-15 | 2006-04-25 | Synergen, Inc. | Pegylation of polypeptides |
US7704944B2 (en) * | 1997-08-14 | 2010-04-27 | Yeda Research And Development Company Ltd. | Interleukin-18 binding proteins, their preparation and use for the treatment of sepsis |
IL121860A0 (en) * | 1997-08-14 | 1998-02-22 | Yeda Res & Dev | Interleukin-18 binding proteins their preparation and use |
WO2002032374A2 (en) * | 2000-10-18 | 2002-04-25 | Immunex Corporation | Methods for treating il-18 mediated disorders |
SI1487541T1 (sl) * | 2002-03-22 | 2009-02-28 | Serono Lab | Uporaba inhibitorjev il-18 za zdravljenje in /alipreventivo bolezni perifernega oĺ˝ilja |
US7005523B2 (en) * | 2002-08-30 | 2006-02-28 | Pfizer Inc. | Cycloalkyl-[4-(trifluorophenyl)-oxazol-5yl]-triazolo-pyridines |
-
2003
- 2003-12-31 IL IL15967003A patent/IL159670A0/xx unknown
-
2004
- 2004-12-27 EP EP04806701A patent/EP1699823A2/en not_active Ceased
- 2004-12-27 CA CA002552155A patent/CA2552155A1/en not_active Abandoned
- 2004-12-27 AU AU2004308763A patent/AU2004308763B2/en not_active Ceased
- 2004-12-27 JP JP2006546476A patent/JP5420151B2/ja not_active Expired - Fee Related
- 2004-12-27 US US10/584,805 patent/US20070264237A1/en not_active Abandoned
- 2004-12-27 WO PCT/IL2004/001170 patent/WO2005063290A2/en active Application Filing
-
2006
- 2006-06-15 IL IL176324A patent/IL176324A/en active IP Right Grant
- 2006-07-27 NO NO20063458A patent/NO20063458L/no not_active Application Discontinuation
-
2011
- 2011-02-15 US US13/027,449 patent/US20110177065A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
IL176324A0 (en) | 2006-10-05 |
JP5420151B2 (ja) | 2014-02-19 |
JP2007517020A (ja) | 2007-06-28 |
NO20063458L (no) | 2006-07-27 |
US20110177065A1 (en) | 2011-07-21 |
AU2004308763A1 (en) | 2005-07-14 |
AU2004308763B2 (en) | 2011-06-16 |
WO2005063290A2 (en) | 2005-07-14 |
CA2552155A1 (en) | 2005-07-14 |
US20070264237A1 (en) | 2007-11-15 |
WO2005063290A3 (en) | 2005-10-13 |
IL176324A (en) | 2013-08-29 |
EP1699823A2 (en) | 2006-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL176324A0 (en) | Il-18 binding protein in inflammations | |
AU2003227861A8 (en) | Protein involved in cancer | |
GB0305267D0 (en) | Proteins involved in apoptosis | |
GB0326192D0 (en) | Proteins involved in signal transduction | |
GB0314894D0 (en) | Improvements in and relating to antennas | |
GB0229875D0 (en) | Protein involved in cancer | |
GB0305351D0 (en) | Oligonucleotide binding protein in cancer | |
GB0305268D0 (en) | Proteins involved in apoptosis | |
GB0305269D0 (en) | Proteins involved in apoptosis | |
GB0305348D0 (en) | Membrane-associated protein in cancer | |
GB0305342D0 (en) | Protein folding in cancer | |
GB0308327D0 (en) | A protein involved in cancer | |
GB0305387D0 (en) | Protein stability and cancer | |
GB0321300D0 (en) | Protein structure and uses thereof | |
GB0305353D0 (en) | Apoptosis-related protein and cancer | |
GB0303632D0 (en) | Secreted protein | |
GB0308610D0 (en) | Secreted protein | |
GB0316704D0 (en) | Protein | |
GB0305829D0 (en) | Protein | |
GB0305450D0 (en) | Protein | |
GB0303938D0 (en) | Protein | |
GB0317013D0 (en) | Protein | |
GB0316098D0 (en) | Protein | |
GB0316562D0 (en) | Protein | |
GB0321297D0 (en) | Protein |